Rheumatology

Filter

New Classification Criteria in SpA: EULAR 2026

June 2026

Classification criteria and recommendations for the diagnosis and clinical management of spondyloarthritis have been updated and were presented at EULAR 2026.

New Classification Criteria in SpA: EULAR 2026

Classification criteria and recommendations for the diagnosis and clinical management of spondyloarthritis have been updated and were presented at EULAR 2026.

Improving the Patient Experience in Rheumatology: EULAR 2026

Researchers have highlighted, at EULAR 2026, different pathways through which the rheumatology patient’s experience can be enhanced.

New Insights in Gout Management: EULAR 2026

Urate-lowering therapy in a treat-to-target strategy can foster higher remission rates in patients with gout, according to new data presented at EULAR 2026.

CAR-T Cell Therapies in Refractory RMD: EULAR 2026

CAR-T cell therapies prove promising in treatment-refractory rheumatic and musculoskeletal diseases, according to new research presented at EULAR 2026.

Review of the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress

THE EUROPEAN Alliance of Associations for Rheumatology (EULAR) 2025 Congress, the most dynamic event of the year for the rheumatology…

Updates From the EULAR 2025 Congress

THE European Alliance of Associations for Rheumatology (EULAR) 2025 Congress was held in Barcelona, Spain, from the…

How to Treat ANCA-Associated Vasculitis

IN A HIGHLY anticipated session presented at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, Benjamin…

EULAR 2025 Interview: Rikke Helene Moe

Rikke Helene Moe – EULAR VP HPR, Senior Researcher at Health Services Research and Innovation Unit (EHI); Center for treatment of…

Loading posts...